pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
AAVB-039
Juvenile Macular Degeneration (Stargardt Disease)
AAVantgarde Bio Srl
0
catalysts
Phase 2
AB-001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Artbio Inc
0
catalysts
Phase 2
AB-002
Thrombosis
Lysyl oxidase homolog 2
Aronora Inc
0
catalysts
Phase 2
← prev
page 3 of 50
next →
131
Pain
89
Neurology
1
AB-1003
Limb-Girdle Muscular Dystrophy
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 2
AB-1009
Pompe Disease
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 2
AB-2100
Metastatic Renal Cell Carcinoma
Arsenal Biosciences Inc
0
catalysts
Phase 2
ABBVCLS-628
Polycystic Kidney Disease
Calico Life Sciences LLC
0
catalysts
Phase 2
ABI-110
Polypoidal Choroidal Vasculopathy
Avirmax Inc
0
catalysts
Phase 2
ABO-101
Primary Hyperoxaluria Type I
Chiesi Farmaceutici SpA
0
catalysts
Phase 2
ABP-745
Gouty Arthritis (Gout)
Atom Therapeutics Co Ltd
0
catalysts
Phase 2
ABS-201
Androgenic Alopecia
Almirall SA
0
catalysts
Phase 2
ABSK-141
Solid Tumor
Abbisko Therapeutics Co Ltd
0
catalysts
Phase 2
ACD-440
Neuropathic Pain (Neuralgia)
AlzeCure Pharma AB
0
catalysts
Phase 2
ACDN-01
Juvenile Macular Degeneration (Stargardt Disease)
Ascidian Therapeutics Inc
0
catalysts
Phase 2
ACE-1831
Immunoglobulin G4-Related Disease (IgG4-RD)
Acepodia Inc
0
catalysts
Phase 2
ACI-24060
Alzheimer's Disease
$ACIU
AC Immune SA
0
catalysts
Phase 2
ACP-01
Vescell
Chronic Stable Angina
Hemostemix Inc
0
catalysts
Phase 2
ACP-017
Cutaneous Squamous Cell Carcinoma (cSCC)
Ascendis Pharma AS
0
catalysts
Phase 2
ACT-001
Pediatric Diffuse Intrinsic Pontine Glioma
Accendatech Co Ltd
0
catalysts
Phase 2
ACTX-401
Spinal Muscular Atrophy (SMA)
Alcyone Therapeutics Inc
0
catalysts
Phase 2
ADCED-01
Soft Tissue Sarcoma
ADCendo ApS
0
catalysts
Phase 2
ADG-116
Solid Tumor
$ADAG
Adagene Inc.
0
catalysts
Phase 2
AFM-24I
Breast Cancer
Affimed GmbH
0
catalysts
Phase 2
AFTX-201
Dilated Cardiomyopathy
Affinia Therapeutics Inc
0
catalysts
Phase 2
AGA-2115
Osteogenesis Imperfecta
Angitia Biopharmaceuticals Ltd
0
catalysts
Phase 2
AGLE-102
Burns
Aegle Therapeutics Corp
0
catalysts
Phase 2
AGT-100216
Charcot-Marie-Tooth Disease Type I A
Augustine Therapeutics NV
0
catalysts
Phase 2
AGuIX
Glioblastoma Multiforme (GBM)
NH TherAguix SAS
0
catalysts
Phase 2
AI-081
Solid Tumor
OncoC4 Inc
0
catalysts
Phase 2
AION-301
Chronic Kidney Disease (Chronic Renal Failure)
AION Healthspan Inc
0
catalysts